Jaye L. Thompson
Hoofd Techniek/Wetenschap/O&O bij GREENWICH LIFESCIENCES, INC.
Vermogen: 4 M $ op 31-05-2024
Profiel
Jaye L.
Thompson is the founder of Synergos, Inc. (founded in 1991) and Proxima Clinical Research, Inc. (founded in 2017).
Dr. Thompson's current job is Director at Gulf Coast Regional Center of Innovation & Commercialization since 2013.
Dr. Thompson is also currently Vice President-Clinical & Regulatory Affairs at Greenwich LifeSciences, Inc. since 2019.
Dr. Thompson's former jobs include Senior Vice President-Clinical & Regulatory at Repros Therapeutics, Inc. from 2013 to 2017, SVP-Clinical Development & Regulatory Affairs at Opexa Therapeutics, Inc. from 2009 to 2013, Advisor at MediGen Group LLC, and SVP-Regulatory Affairs & Emerging Biotechnologies at inVentiv Clinical Solutions LLC in 2009.
Dr. Thompson's education includes an undergraduate degree from Texas A&M University and graduate and doctorate degrees from Texas University of Health Center at San Antonio.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 27-10-2023 | 260 348 ( 2.02% ) | 4 M $ | 31-05-2024 |
Actieve functies van Jaye L. Thompson
| Bedrijven | Functie | Begin |
|---|---|---|
| GREENWICH LIFESCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2019 |
| Gulf Coast Regional Center of Innovation & Commercialization | Directeur/Bestuurslid | - |
Eerdere bekende functies van Jaye L. Thompson
| Bedrijven | Functie | Einde |
|---|---|---|
| REPROS THERAPEUTICS INC | Hoofd Techniek/Wetenschap/O&O | - |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Hoofd Techniek/Wetenschap/O&O | 01-04-2013 |
| inVentiv Clinical Solutions LLC | Algemeen Adviseur | 01-01-2009 |
Proxima Clinical Research, Inc.
 Proxima Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Proxima Clinical Research, Inc. is a contract research organization that provides regulatory and clinical research expertise to life sciences companies of all sizes and stages. The private company is based in Houston, TX, within the Texas Medical Center, the largest medical center in the world. Proxima CRO partners with medical device, pharmaceutical, biotechnology, and diagnostic firms across 18 countries and five continents to further advance the $130 billion industry. The company was founded by Kevin Coker, Jaye L. Thompson, Larry Wayne Lawson, and Kevin Coker has been the CEO since incorporation. | Oprichter | - |
Synergos, Inc.
 Synergos, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Syneos Health, Inc., Synergos, Inc. provides clinical trial management services. The company is based in The Woodlands, TX. The company was founded by Jaye L. Thompson. Synergos was acquired by Ventiv Health, Inc. on April 05, 2006 for $5.75 million. | Oprichter | - |
Opleiding van Jaye L. Thompson
| Texas A&M University | Undergraduate Degree |
| Texas University of Health Center at San Antonio | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GREENWICH LIFESCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 7 |
|---|---|
MediGen Group LLC
 MediGen Group LLC Investment ManagersFinance Founded in 2001 by Ronald Zimmerman, MediGen Group LLC is a venture capital firm located in Houston, Texas | Finance |
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Health Technology |
Synergos, Inc.
Synergos, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Syneos Health, Inc., Synergos, Inc. provides clinical trial management services. The company is based in The Woodlands, TX. The company was founded by Jaye L. Thompson. Synergos was acquired by Ventiv Health, Inc. on April 05, 2006 for $5.75 million. | Commercial Services |
| Gulf Coast Regional Center of Innovation & Commercialization | |
| inVentiv Clinical Solutions LLC | |
Proxima Clinical Research, Inc.
Proxima Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Proxima Clinical Research, Inc. is a contract research organization that provides regulatory and clinical research expertise to life sciences companies of all sizes and stages. The private company is based in Houston, TX, within the Texas Medical Center, the largest medical center in the world. Proxima CRO partners with medical device, pharmaceutical, biotechnology, and diagnostic firms across 18 countries and five continents to further advance the $130 billion industry. The company was founded by Kevin Coker, Jaye L. Thompson, Larry Wayne Lawson, and Kevin Coker has been the CEO since incorporation. | Commercial Services |
